Characteristics | Treatment outcome | P- value | Adjusted Odds Ratio (AOR) (95% CI) | |
---|---|---|---|---|
Successful Treatment | Unsuccessful treatment | |||
Pretreatment Weight | ||||
 20–29 Kg | 4 (80.0%) | 1 (20.0%) | 0. 843 | 0.92 (0.38–2.19) |
 30–39 Kg | 16 (72.7%) | 6 (27.3%) | 0.244 | 0.22 (0.02–2.79) |
 40–54 Kg | 135 (86.5%) | 21 (13.5%) | 0.150 | 0.40 (0.12–1.39) |
  > 54 Kg | 148 (89.2%) | 18 (10.8%) |  | 1.00 |
Pretreatment BMI (kg/m2) | ||||
  < 18.5 | 81 (82.7%) | 17 (17.3%) |  | 1.00 |
 18.5–24.9 | 176 (87.6%) | 25 (12.4%) | 0.834 | 0.85 (0.18–4.01) |
  ≥ 25 | 46 (92.0%) | 4 (8.0%) | 0.497 | 0.64 (0.17–2.34) |
Patient category | ||||
 New cases | 273 (88.1%) | 37 (11.9%) | 0.022 | 1.00 |
 Re treatment | 30 (76.9%) | 9 (23.1%) | 2.91 (1.17–7.28) | |
Types of TB | ||||
 SPP TB | 90 (81.1%) | 21 (18.9%) |  | 1.00 |
 EP TB | 102 (85.7%) | 17 (14.3%) | 0.003 | 0.23 (0.09–0.62) |
 SNP TB | 111 (93.3%) | 8 (6.7%) | 0.032 | 0.34 (0.13–0.91) |
WHO staging | ||||
 stage 1 | 72 (91.1%) | 7 (8.9%) |  | 1.00 |
 stage 2 | 94 (92.2%) | 8 (7.8%) | 0.022 | 4.46 (1.24–16.02) |
 stage 3 | 109 (85.2%) | 19 (14.8%) | 0.003 | 5.94 (1.87–18.85) |
 stage 4 | 28 (70.0%) | 12 (30.0%) | 0.025 | 3.01 (1.15–7.91) |
History of opportunistic infection | ||||
 No | 149 (93.7%) | 10 (6.3%) | 0.002 | 1.00 |
 Yes | 154 (81.1%) | 36 (18.9%) | 3.68 (1.62–8.33) | |
CPT initiated | ||||
 Yes | 264 (89.2%) | 32 (10.8%) | 0.002 | 1.00 |
 No | 39 (73.6%) | 14 (26.4%) | 3.54 (1.59–7.89) | |
CD4 count | ||||
  < 200 cells/μL | 83 (81.4%) | 19 (18.6%) |  | 1.00 |
 201–499 cells/μL | 155 (90.1%) | 17 (9.9%) | 0.451 | 1.50 (0.52–4.33) |
 ≥ 500 cells/μL | 65 (86.7%) | 10 (13.3%) | 0.433 | 1.47 (0.56–3.82) |